UPEXI INC (UPXI) Fundamental Analysis & Valuation
NASDAQ:UPXI • US39959A2050
Current stock price
1.315 USD
+0.07 (+6.05%)
Last:
This UPXI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. UPXI Profitability Analysis
1.1 Basic Checks
- UPXI had negative earnings in the past year.
- In the past year UPXI has reported a negative cash flow from operations.
- UPXI had negative earnings in 4 of the past 5 years.
- The reported operating cash flow has been mixed in the past 5 years: UPXI reported negative operating cash flow in multiple years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -45.34%, UPXI is doing worse than 78.38% of the companies in the same industry.
- UPXI has a Return On Equity of -252.35%. This is in the lower half of the industry: UPXI underperforms 78.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -45.34% | ||
| ROE | -252.35% | ||
| ROIC | N/A |
ROA(3y)-46.06%
ROA(5y)-26.35%
ROE(3y)-146%
ROE(5y)-86.3%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Gross Margin value of 80.67%, UPXI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- UPXI's Gross Margin has improved in the last couple of years.
- UPXI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 80.67% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.17%
GM growth 5Y14.66%
2. UPXI Health Analysis
2.1 Basic Checks
- UPXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, UPXI has more shares outstanding
- The number of shares outstanding for UPXI has been increased compared to 5 years ago.
- The debt/assets ratio for UPXI has been reduced compared to a year ago.
2.2 Solvency
- UPXI has an Altman-Z score of -2.50. This is a bad value and indicates that UPXI is not financially healthy and even has some risk of bankruptcy.
- UPXI has a worse Altman-Z score (-2.50) than 78.38% of its industry peers.
- UPXI has a Debt/Equity ratio of 4.25. This is a high value indicating a heavy dependency on external financing.
- UPXI has a worse Debt to Equity ratio (4.25) than 78.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.25 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.5 |
ROIC/WACCN/A
WACC8.08%
2.3 Liquidity
- A Current Ratio of 2.20 indicates that UPXI has no problem at all paying its short term obligations.
- UPXI has a Current ratio of 2.20. This is in the better half of the industry: UPXI outperforms 62.16% of its industry peers.
- A Quick Ratio of 2.19 indicates that UPXI has no problem at all paying its short term obligations.
- UPXI has a better Quick ratio (2.19) than 78.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.2 | ||
| Quick Ratio | 2.19 |
3. UPXI Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 75.76% over the past year.
- UPXI shows a strong growth in Revenue. In the last year, the Revenue has grown by 329.54%.
- The Revenue has been growing by 16.37% on average over the past years. This is quite good.
EPS 1Y (TTM)75.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-136.29%
Revenue 1Y (TTM)329.54%
Revenue growth 3Y-11.83%
Revenue growth 5Y16.37%
Sales Q2Q%101.02%
3.2 Future
- Based on estimates for the next years, UPXI will show a very strong growth in Earnings Per Share. The EPS will grow by 20.24% on average per year.
- Based on estimates for the next years, UPXI will show a very strong growth in Revenue. The Revenue will grow by 33.30% on average per year.
EPS Next Y-3.8%
EPS Next 2Y20.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year120.96%
Revenue Next 2Y33.3%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. UPXI Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for UPXI. In the last year negative earnings were reported.
- Also next year UPXI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as UPXI's earnings are expected to grow with 20.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.24%
EPS Next 3YN/A
5. UPXI Dividend Analysis
5.1 Amount
- No dividends for UPXI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
UPXI Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:UPXI (4/30/2026, 2:10:17 PM)
1.315
+0.07 (+6.05%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Industry Strength2.48
Industry Growth34.16
Earnings (Last)02-10 2026-02-10/amc
Earnings (Next)05-12 2026-05-12
Inst Owners27.34%
Inst Owner Change-0.01%
Ins Owners8.09%
Ins Owner Change5.29%
Market Cap91.73M
Revenue(TTM)24.74M
Net Income(TTM)-122.93M
Analysts82.5
Price Target5.1 (287.83%)
Short Float %31.59%
Short Ratio3.24
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)843.14%
Min EPS beat(2)-5664.71%
Max EPS beat(2)7350.98%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.63%
Min Revenue beat(2)-16.2%
Max Revenue beat(2)-1.06%
Revenue beat(4)1
Avg Revenue beat(4)-22.67%
Min Revenue beat(4)-82.88%
Max Revenue beat(4)9.44%
Revenue beat(8)1
Avg Revenue beat(8)-74.08%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-52.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-111.11%
EPS NY rev (1m)0%
EPS NY rev (3m)-497.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16.52%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.71 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.88 | ||
| P/tB | 1.94 | ||
| EV/EBITDA | N/A |
EPS(TTM)-5.29
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.78
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.35
BVpS0.7
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -45.34% | ||
| ROE | -252.35% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 80.67% | ||
| FCFM | N/A |
ROA(3y)-46.06%
ROA(5y)-26.35%
ROE(3y)-146%
ROE(5y)-86.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.17%
GM growth 5Y14.66%
F-Score5
Asset Turnover0.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.25 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 6558.83% | ||
| Cap/Sales | 150.47% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.2 | ||
| Quick Ratio | 2.19 | ||
| Altman-Z | -2.5 |
F-Score5
WACC8.08%
ROIC/WACCN/A
Cap/Depr(3y)31.59%
Cap/Depr(5y)86.46%
Cap/Sales(3y)2.4%
Cap/Sales(5y)7.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-136.29%
EPS Next Y-3.8%
EPS Next 2Y20.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)329.54%
Revenue growth 3Y-11.83%
Revenue growth 5Y16.37%
Sales Q2Q%101.02%
Revenue Next Year120.96%
Revenue Next 2Y33.3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1409.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-677.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-205.66%
OCF growth 3YN/A
OCF growth 5YN/A
UPEXI INC / UPXI Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for UPEXI INC?
ChartMill assigns a fundamental rating of 3 / 10 to UPXI.
What is the valuation status of UPEXI INC (UPXI) stock?
ChartMill assigns a valuation rating of 1 / 10 to UPEXI INC (UPXI). This can be considered as Overvalued.
What is the profitability of UPXI stock?
UPEXI INC (UPXI) has a profitability rating of 2 / 10.
What is the earnings growth outlook for UPEXI INC?
The Earnings per Share (EPS) of UPEXI INC (UPXI) is expected to decline by -3.8% in the next year.